
Robert Toto
Associate Dean of Clinical and Translational Research · UT Southwestern’s Graduate School of Biomedical Sciences
Credentials: ·
History
- Present
Clinical and Translational Research · UT Southwestern’s Graduate School of Biomedical Sciences
Present
1982–1983- 1980–1981
U.S. Public Health Service Hospital
- 1979–1980
- 1978–1979
University of Michigan Hospitals and Health Centers
- 1977–1978
University of Michigan Hospitals and Health Centers
Research
Dapagliflozin in Patients with Chronic Kidney Disease
New England Journal of Medicine · 2020 · 4,258 citations
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
New England Journal of Medicine · 2009 · 1,645 citations
JAMA · 2002 · 1,581 citations

39 papers
- GB
21 papers

19 papers · 6 as a fellow

18 papers

17 papers

16 papers
- JI
14 papers
- LA
14 papers
Grants
- 2022–2027
Kidney Precision Medicine Project - Patient Engagement
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $2M · Ut Southwestern Medical Center
- 2021–2027
UT Southwestern Center for Translational Medicine
National Center for Advancing Translational Sciences · UL1
Contact PI · $39.3M · Ut Southwestern Medical Center
- 2017–2023
Chronic Kidney Disease Precision Medicine Project
National Institute of Diabetes and Digestive and Kidney Diseases · UH3
PI · $899.8K · Ut Southwestern Medical Center
- 2019–2021
National Heart, Lung, and Blood Institute · R21
Contact PI · $256.8K · Ut Southwestern Medical Center
Clinical trials
- 2022–2025
Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4
Principal investigator · Completed
University of Texas Southwestern Medical Center
- 2007–2008
African American Study of Kidney Disease and Hypertension ABPM Pilot Study
Principal investigator · Completed · Phase 2, Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2003–2006
Improving Outcomes in Patients With Kidney Disease Due to Diabetes
Principal investigator · Completed · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 1999–2003
Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
Study chair · Completed · Phase 1
University of Texas

